Global Big Data confirm Remdesivir to be a Recommended Antiviral Drug to Fight COVID-19

Abstract

COVID-19 is the latest deadly virus to haunt the world. The virus is so contagious it needs a precise drug for treating patients who contract it. The purpose of this study is to observe trends and relevant points of information about Remdesivir in global big data. This article describes a new method of collecting data, namely data mining from Google trends. The subjects under consideration is how Remdesivir is used in the USA, Russia, and India, as they are the current countries with the most COVID-19-positive cases. This method enabled us to discover how many topics on the internet related to Remdesivir, as well as how strong the relevance of this topic was in those three countries. The results shows that the USA had the biggest relevance score in the information search (8.86 points), but the information trends were quite static. Russia had fluctuating trends but the lowest relevance score. India had a dynamic trend recently and a higher relevance score than Russia. It can be concluded that medical authorities are the cause behind information trends for Remdesivir in these three countries that have approved clinical trials for the use of Remdesivir as a COVID-19 treatment.